Hsbc Holdings PLC Purchases 172,435 Shares of Novanta Inc. $NOVT

Hsbc Holdings PLC grew its position in shares of Novanta Inc. (NASDAQ:NOVT) by 1,355.6% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 185,155 shares of the technology company’s stock after purchasing an additional 172,435 shares during the period. Hsbc Holdings PLC owned approximately 0.52% of Novanta worth $21,964,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Conestoga Capital Advisors LLC boosted its stake in Novanta by 3.4% during the fourth quarter. Conestoga Capital Advisors LLC now owns 1,458,259 shares of the technology company’s stock valued at $173,518,000 after buying an additional 47,540 shares during the period. Allspring Global Investments Holdings LLC boosted its position in shares of Novanta by 75.9% during the 4th quarter. Allspring Global Investments Holdings LLC now owns 1,399,462 shares of the technology company’s stock valued at $155,536,000 after acquiring an additional 604,055 shares during the last quarter. State Street Corp boosted its position in shares of Novanta by 1.0% during the 4th quarter. State Street Corp now owns 1,319,474 shares of the technology company’s stock valued at $157,004,000 after acquiring an additional 13,603 shares during the last quarter. Wasatch Advisors LP grew its holdings in shares of Novanta by 10.6% during the second quarter. Wasatch Advisors LP now owns 1,100,029 shares of the technology company’s stock worth $141,827,000 after purchasing an additional 104,985 shares in the last quarter. Finally, Bamco Inc. NY grew its holdings in shares of Novanta by 49.4% during the fourth quarter. Bamco Inc. NY now owns 936,962 shares of the technology company’s stock worth $111,489,000 after purchasing an additional 309,869 shares in the last quarter. Institutional investors own 98.35% of the company’s stock.

Novanta Stock Down 10.3%

Shares of NOVT opened at $147.85 on Wednesday. The firm has a market cap of $5.58 billion, a P/E ratio of 107.14 and a beta of 1.67. The stock has a 50 day simple moving average of $153.70 and a two-hundred day simple moving average of $137.75. The company has a debt-to-equity ratio of 0.15, a current ratio of 3.56 and a quick ratio of 2.69. Novanta Inc. has a 1 year low of $98.27 and a 1 year high of $171.85.

Novanta (NASDAQ:NOVT) last announced its quarterly earnings data on Monday, May 11th. The technology company reported $0.81 earnings per share for the quarter, topping analysts’ consensus estimates of $0.78 by $0.03. Novanta had a net margin of 5.35% and a return on equity of 12.06%. The firm had revenue of $257.71 million during the quarter, compared to analyst estimates of $253.40 million. During the same period in the previous year, the business posted $0.74 EPS. The business’s quarterly revenue was up 10.4% on a year-over-year basis. Novanta has set its FY 2026 guidance at 3.500-3.650 EPS and its Q2 2026 guidance at 0.810-0.860 EPS. On average, analysts forecast that Novanta Inc. will post 3.59 earnings per share for the current fiscal year.

Analysts Set New Price Targets

NOVT has been the subject of a number of research reports. Robert W. Baird set a $180.00 price target on shares of Novanta in a research note on Tuesday, June 9th. Wall Street Zen upgraded shares of Novanta from a “hold” rating to a “buy” rating in a research report on Saturday, June 27th. Finally, Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Novanta in a report on Friday, April 17th. One investment analyst has rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat.com, Novanta has a consensus rating of “Hold” and a consensus price target of $180.00.

Insiders Place Their Bets

In related news, CEO Matthijs Glastra sold 6,500 shares of the company’s stock in a transaction on Thursday, July 2nd. The shares were sold at an average price of $161.13, for a total transaction of $1,047,345.00. Following the completion of the sale, the chief executive officer directly owned 29,761 shares in the company, valued at $4,795,389.93. This represents a 17.93% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 20,500 shares of company stock valued at $3,020,895 in the last ninety days. Insiders own 1.20% of the company’s stock.

About Novanta

Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.

Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.